Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Psychoneuroendocrinology|October 26, 2013
Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interactionJames K Rilling, Ashley C DeMarco, Patrick D Hackett, et al.
Brain, Behavior, and Immunity|April 5, 2016
Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorderDavid R Goldsmith, Ebrahim Haroon, Bobbi J Woolwine, et al.
Research Square|July 9, 2025
Polygenic score for C-reactive protein is associated with accelerated cortical thinning and increased psychopathology in adolescents: a population-based longitudinal cohort studyHaixia Zheng, Jonathan Savitz, Ebrahim Haroon, et al.
Molecular Psychiatry|June 14, 2018
What does plasma CRP tell us about peripheral and central inflammation in depression?Jennifer C Felger, Ebrahim Haroon, Trusharth A Patel, et al.
NPJ Schizophrenia|April 3, 2020
Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controlsDavid R Goldsmith, Nicholas Massa, Bradley D Pearce, et al.
Brain, Behavior, and Immunity|January 1, 2026
Effects of Dopaminergic therapy with levodopa (L-DOPA) on fear and Anxiety-Related circuits and symptoms in patients with depression and higher inflammationGenevieve E Craig, Neeti D Mehta, Mandakh Bekhbat, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 24, 2025
Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophreniaDavid R Goldsmith, Courtney S Ning, Gregory P Strauss, et al.
Nature. Mental Health|March 13, 2026
Polygenic score for C-reactive protein is linked to faster cortical thinning and psychopathology risk in adolescentsHaixia Zheng, Jonathan Savitz, Ebrahim Haroon, et al.
Brain, Behavior, and Immunity|November 30, 2018
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosisDavid R Goldsmith, Ebrahim Haroon, Andrew H Miller, et al.
Research Square|March 18, 2024
A randomized proof-of-mechanism trial of TNF antagonism for motivational anhedonia and related corticostriatal circuitry in depressed patients with high inflammationMichael Treadway, Sarah Etuk, Jessica Cooper, et al.
Pageof 7